Frovatriptan Succinate Tablet — FDA Drug Shortage

To Be Discontinued — Endo Pharmaceuticals, Inc.

The FDA lists a drug shortage record for Frovatriptan Succinate Tablet (tablet) from Endo Pharmaceuticals, Inc. with status To Be Discontinued. The shortage was first posted on 02/24/2026.

Shortage Details

Status
To Be Discontinued
Company
Endo Pharmaceuticals, Inc.
Package NDC
63481-025-09
Dosage Form
Tablet
Presentation
Frova, Tablet, 2.5 mg (NDC 63481-025-09)
Initial Posting
02/24/2026
Revised Date